WHO alert on Gambia deaths: DCGA initiates probe; Haryana sends cough syrup samples to Kolkata lab


Content Team
Image Credit: FPJ

India's drug regulator has initiated a probe and sought further details from the WHO after the global health body issued an alert that cough syrups manufactured by an Indian firm could potentially be linked to the death of children in Gambia. WHO on Wednesday warned that four "contaminated" and "substandard" cough syrups allegedly produced by Maiden Pharmaceuticals Limited could be the reason for the deaths.